Annual EBITDA
-$3.76B$473.00M-14.41%
Summary
- Current Value
- As of today, MRNA annual EBITDA is -$3.76B, down -14.41% on
- Historical Performance
- MRNA annual EBITDA is down -127.76% over the past 3 years, and down -629.32% over the past 5 years
- All-Time High Comparison
- MRNA annual EBITDA is currently -127.76% below its historical high of $13.53B set on
- 3-Year Low Comparison
- MRNA annual EBITDA is at its 3-year low
- Sector Comparison
- MRNA annual EBITDA is higher than 0.08% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$3.76B | -14.4% | -127.8% | -629.3% | -10000.0% | |
| Quarterly EBITDA | -$208.00M | -1055.6% | -116.9% | +8.2% | -2635.0% | |
| TTM EBITDA | -$3.26B | -37.3% | -124.2% | -455.3% | -10000.0% | |
| Price | $33.84 | -3.7% | -82.4% | -72.7% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $3.24B | -52.7% | -82.4% | +5274.6% | +10000.0% | |
| Annual EPS | -$9.27 | +24.9% | -132.8% | -496.8% | +99.5% | |
| Annual EBIT | -$3.95B | -1.1% | -129.7% | -622.5% | -10000.0% | |
| Annual Net Income | -$3.56B | +24.5% | -129.2% | -592.8% | -10000.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.95B | N/A | -137.7% |
| 5Y | $13.53B | -127.8% | |
| All | $13.53B | -127.8% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$3.76B | at low | |
| 5Y | -$3.76B | at low | |
| All | -$3.76B | at low |
EBITDA History
FAQ
What is the current annual EBITDA of MRNA?
As of today, MRNA annual EBITDA is -$3.76B
What is 1-year change in MRNA annual EBITDA?
MRNA annual EBITDA is down -14.41% year-over-year
What is 3-year change in MRNA annual EBITDA?
MRNA annual EBITDA is down -127.76% over the past 3 years
How far is MRNA annual EBITDA from its all-time high?
MRNA annual EBITDA is currently -127.76% below its historical high of $13.53B set on December 31, 2021
How does MRNA annual EBITDA rank versus sector peers?
MRNA annual EBITDA is higher than 0.08% of companies in Healthcare sector
When is MRNA next annual earnings release?
The next annual earnings release for MRNA is on
Quarterly EBITDA
-$208.00M$642.00M+75.53%
Summary
- Current Value
- As of today, MRNA quarterly EBITDA is -$208.00M, up +75.53% on
- Historical Performance
- MRNA quarterly EBITDA is down -1055.56% year-over-year, and down -116.92% over the past 3 years
- All-Time High Comparison
- MRNA quarterly EBITDA is currently -103.84% below its historical high of $5.42B set on
- 3-Year Low Comparison
- MRNA quarterly EBITDA is +88.29% above its 3-year low of -$1.78B reached on
- Sector Comparison
- MRNA quarterly EBITDA is higher than 0.72% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$208.00M | +75.5% | -1055.6% | -116.9% | +8.2% | |
| Annual EBITDA | -$3.76B | – | -14.4% | -127.8% | -629.3% | |
| TTM EBITDA | -$3.26B | -6.2% | -37.3% | -124.2% | -455.3% | |
| Price | $33.84 | +26.6% | -3.7% | -82.4% | -72.7% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $1.02B | +615.5% | -45.4% | -69.3% | +543.4% | |
| Quarterly EPS | -$0.51 | +75.9% | -1673.0% | -120.3% | +13.4% | |
| Quarterly EBIT | -$260.00M | +71.3% | -271.4% | -123.3% | -10.6% | |
| Quarterly Net Income | -$200.00M | +75.8% | -1638.5% | -119.2% | +14.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$208.00M | at high | |
| 3Y | $1.60B | N/A | -113.0% |
| 5Y | $5.42B | -103.8% | |
| All | $5.42B | -103.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$1.19B | N/A | +82.5% |
| 3Y | -$1.78B | +88.3% | |
| 5Y | -$1.78B | +88.3% | |
| All | -$1.78B | +88.3% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of MRNA?
As of today, MRNA quarterly EBITDA is -$208.00M
What is MRNA quarterly EBITDA most recent change?
MRNA quarterly EBITDA was up +75.53% on September 30, 2025
What is 1-year change in MRNA quarterly EBITDA?
MRNA quarterly EBITDA is down -1055.56% year-over-year
How far is MRNA quarterly EBITDA from its all-time high?
MRNA quarterly EBITDA is currently -103.84% below its historical high of $5.42B set on December 31, 2021
How does MRNA quarterly EBITDA rank versus sector peers?
MRNA quarterly EBITDA is higher than 0.72% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
TTM EBITDA
-$3.26B$190.00M-6.20%
Summary
- Current Value
- As of today, MRNA TTM EBITDA is -$3.26B, down -6.20% on
- Historical Performance
- MRNA TTM EBITDA is down -37.34% year-over-year, and down -124.23% over the past 3 years
- All-Time High Comparison
- MRNA TTM EBITDA is currently -119.76% below its historical high of $16.47B set on
- 3-Year Low Comparison
- MRNA TTM EBITDA is +28.77% above its 3-year low of -$4.57B reached on
- Sector Comparison
- MRNA TTM EBITDA is higher than 0.09% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$3.26B | -6.2% | -37.3% | -124.2% | -455.3% | |
| Annual EBITDA | -$3.76B | – | -14.4% | -127.8% | -629.3% | |
| Quarterly EBITDA | -$208.00M | +75.5% | -1055.6% | -116.9% | +8.2% | |
| Price | $33.84 | +26.6% | -3.7% | -82.4% | -72.7% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $2.23B | -27.5% | -56.0% | -89.5% | +804.7% | |
| TTM EPS | -$8.06 | -7.3% | -38.4% | -129.2% | -397.1% | |
| TTM EBIT | -$3.46B | -5.8% | -28.2% | -126.5% | -459.8% | |
| TTM Net Income | -$3.12B | -7.3% | -40.1% | -126.5% | -420.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$3.07B | -6.2% | |
| 3Y | $9.61B | N/A | -133.9% |
| 5Y | $16.47B | -119.8% | |
| All | $16.47B | -119.8% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$3.76B | N/A | +13.3% |
| 3Y | -$4.57B | +28.8% | |
| 5Y | -$4.57B | +28.8% | |
| All | -$4.57B | +28.8% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of MRNA?
As of today, MRNA TTM EBITDA is -$3.26B
What is MRNA TTM EBITDA most recent change?
MRNA TTM EBITDA was down -6.20% on September 30, 2025
What is 1-year change in MRNA TTM EBITDA?
MRNA TTM EBITDA is down -37.34% year-over-year
How far is MRNA TTM EBITDA from its all-time high?
MRNA TTM EBITDA is currently -119.76% below its historical high of $16.47B set on March 31, 2022
How does MRNA TTM EBITDA rank versus sector peers?
MRNA TTM EBITDA is higher than 0.09% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1682852/000168285225000075/0001682852-25-000075-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000168285225000022/0001682852-25-000022-index.htm
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna